• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,277.48 121.86
( 0.16%)
Global Indices
Nasdaq
51,515.27 -505.40
(-0.97%)
Dow Jones
7,441.22 -91.13
(-1.21%)
Hang Seng
69,975.80 571.30
(0.82%)
Nikkei 225
10,505.62 11.41
(0.11%)
Forex
USD-INR
94.55 -0.09
(-0.09%)
EUR-INR
109.66 -0.13
(-0.12%)
GBP-INR
126.84 -0.25
(-0.20%)
JPY-INR
0.59 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
93.2373503
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
145.48
436666.97
EPS(TTM)
Face Value()
Div & Yield %
12.51
1
0.88
 

marsons ltd
Marsons spurts after securing transformer repair order from WBSETCL
Jun 09,2026

The contract involves repairing, inspection and testing of 50 MVA, 132/33 KV power transformers, including transportation of the equipment to and from project locations.

The order has been awarded by a domestic entity and is scheduled to be executed over a period of 6-12 months, the company said in a regulatory filing.

The total value of the contract stands at Rs 9,48,36,600.

Marsons clarified that neither its promoters nor promoter group entities have any interest in the awarding entity. The company also stated that the contract does not fall under related-party transactions.

Marsons is engaged in the business of manufacturing, trading & servicing transformers, transformer goods & other rental income. The company’s consolidated net profit surged 151.6% to Rs 22.62 crore on a 66% increase in net sales to Rs 92.65 crore in Q4 FY26 over Q4 FY25.